| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Sep―12 |
The Cerebral Haemorrhage and SARS-CoV-2: An Emerging Virus From a Meta-Analysis Perspective |
Yuxia Wang, Chao Zhang, Yunzhu Zhang, Zhuwei Zhang |
| 2 |
[GO] |
2025―Jul―26 |
The Role of Emerging/Re-Emerging RNA Viruses in Bone-Related Diseases With a Focus on DENV, CHIKV, and SARS-CoV-2 |
Jinxi Zhang, Jiandong Guo, Jian Li, Jiawei Gao, Jie Liu, Shuying Shen, Jianglong Zhu |
| 3 |
[GO] |
2025―Jul―17 |
An Overview of Ophthalmic Complications Associated With Emerging/Re-Emerging Viruses: Focus on ZIKV, DENV, SARS-CoV-2, and MPXV |
Qian Li, Wenbo Jiao, Xiaolin Li, Lingling Liang |
| 4 |
[GO] |
2025―Jul―15 |
Oral Manifestations in the Post COVID-19 Condition: A Systematic Review With Meta-Analysis |
Letícia Simeoni Avais, Elis Carolina Pacheco, Luisa Pereira de Oliveira Zanetti Gomes, Márcia Helena Baldani, Camila Marinelli Martins, Eliseu Alves Waldman, Jean Paul J. Gonzalez, Tomoko Y. Steen, Pollyanna Kássia de Oliveira Borges |
| 5 |
[GO] |
2025―Apr―10 |
Emerging Viral Infections (ZIKV, SARS-CoV-2, and MPXV) and Depression: Ketamine and (S, R)-Ketamine as Promising Antidepressants |
Qianqian Cao, Ning Zhang, Cuibo Leng, Shoushi Wang, Jun Ma |
| 6 |
[GO] |
2025―Apr―08 |
Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection |
Soraya Mezouar, Jean-Louis Mege |
| 7 |
[GO] |
2025―Mrz―30 |
Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection |
Soraya Mezouar, Jean-Louis Mege |
| 8 |
[GO] |
2025―Mrz―28 |
Sex-Based Differences in Cardiovascular Outcomes Associated With COVID-19: A Systematic Review and Meta-Analysis |
Tareq M. Abubasheer, Hanan M. A. Abubasheer, Ramez M. Odat, Anas Elgenidy, Ahmed M. Afifi |
| 9 |
[GO] |
2025―Mrz―13 |
Oral SARS-CoV-2 Infection and Risk for Long Covid |
Joel Schwartz, Kristelle Capistrano, Heba Hussein, Avin Hafedi, Deepak Shukla, Afsar Naqvi |
| 10 |
[GO] |
2025―Mrz―11 |
Regulation of miRNA in Cytokine Storm (CS) of COVID-19 and Other Viral Infection: An Exhaustive Review |
Chiranjib Chakraborty, Manojit Bhattacharya, Arpita Das, Abinit Saha |
| 11 |
[GO] |
2025―Mrz―10 |
Emerging Nipah Virus With Pandemic Potential and High Mortality Rates: Is the Scientific Community Learning From Former Pandemics? |
Doris Klingelhöfer, Markus Braun, Christina A. Naser, Dörthe Brüggmann, David A. Groneberg |
| 12 |
[GO] |
2025―Mrz―10 |
Effect of Comorbidities on the Mortality of Patients With COVID-19: A Systematic Review of Reviews and Meta-Analyses |
Karla Larissa Trassi Ganaza-Domingues, Áquila Carolina Fernandes Herculano Ramos-Milaré, Daniele Stéfanie Sara Lopes Lera-Nonose, Aline Ávila Brustolin, Larissa Ferreira de Oliveira, Jonathan Sanches Rosa, Allyson Yuiti Otofuji Inada, Amanda Larissa Dias Leme, Beatriz Ignácio Pinel, Brenda Serenini Perina, Mariana de Souza Terron, Thaís da Silva Santos, Izabel Galhardo Demarchi, Maria Valdrinez Campana Lonardoni, Jorge Juarez Vieira Teixeira |
| 13 |
[GO] |
2024―Nov―29 |
Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series |
Omar Al-omoush, Leen Khalil, Alaa Ramadan, Husam Tarakhan, Ahmad Alzoubi, Abdallah Nabil, Momen Hajali, Basel Abdelazeem, Othman Saleh |
| 14 |
[GO] |
2024―Nov―19 |
Neuroinflammation in Post COVID-19 Sequelae: Neuroinvasion and Neuroimmune Crosstalk |
Roberta S. Dos Reis, Sathish Selvam, Velpandi Ayyavoo |
| 15 |
[GO] |
2024―Sep―27 |
The Assessment of Anti-SARS-CoV-2 Antibodies in Different Vaccine Platforms: A Systematic Review and Meta-Analysis of COVID-19 Vaccine Clinical Trial Studies |
Mohammad Mirzakhani, Maryam Bayat, Mohammadreza Dashti, Safa Tahmasebi, Maryam Rostamtabar, Hadi Esmaeili Gouvarchin Ghaleh, Jafar Amani |
| 16 |
[GO] |
2024―Sep―18 |
Autoantibodies in COVID-19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives |
Srijan Chatterjee, Manojit Bhattacharya, Sanskriti Saxena, Sang-Soo Lee, Chiranjib Chakraborty |
| 17 |
[GO] |
2024―Aug―28 |
Virus-Induced Host Chemokine CCL2 in COVID-19 Pathogenesis: Potential Prognostic Marker and Target of Anti-Inflammatory Strategy |
Abdul Wahid Ansari, Fareed Ahmad, Majid Ali Alam, Thesni Raheed, Ahmed Zaqout, Muna Al-Maslamani, Aamir Ahmad, Joerg Buddenkotte, Abdullatif Al-Khal, Martin Steinhoff |
| 18 |
[GO] |
2024―Aug―01 |
Authors' Response: Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Controlled and Randomized Clinical Trials |
Jayesh Beladiya, Anup Kumar, Yogesh Vasava, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, Sandip Dholakia, Devang Sheth, Sai H. S. Boddu, Chirag A. Patel |
| 19 |
[GO] |
2024―Jul―11 |
Test accuracy of rapid diagnostic tests and reverse-transcription polymerase chain reaction against virus isolation in cell culture for assessing SARS-CoV-2 infectivity: Systematic review and meta-analysis |
Alexey Fomenko, Theo Dähne, Stephanie Weibel, Marcus Panning, Kathrin Grummich, Sabrina Schlesinger, Gerta Rücker, Hartmut Hengel |
| 20 |
[GO] |
2024―Jun―28 |
Follicular oocyte as a potential target for severe acute respiratory syndrome coronavirus 2 infection |
Pramod K. Yadav, Ashutosh N. Pandey, Karuppanan V. Premkumar, Meenakshi Tiwari, Ajai K. Pandey, Shail K. Chaube |
| 21 |
[GO] |
2024―Jun―26 |
Exosomes, and the potential for exosome-based interventions against COVID-19 |
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, Kimia Behzad Moghadam, Zahra Vaziri, Ali Hosein Tabar Kashi, Reza Adabi Firoozjah, Mehrdad Jafari Tadi, Maryam Zolfaghari Dehkharghani, Hadi Valadi, Ali Akbar Moghadamnia, Robin B. Gasser, Ali Rostami |
| 22 |
[GO] |
2024―Jun―08 |
Azvudine versus Paxlovid in COVID-19: A systematic review and meta-analysis |
Behnam Amani, Bahman Amani |
| 23 |
[GO] |
2024―Jun―03 |
Fluvoxamine and long COVID: Post-acute recovery |
Angela M. Reiersen, Charles F. Zorumski, Eric J. Lenze |
| 24 |
[GO] |
2024―Mai―24 |
SARS-CoV-2, periodontal pathogens, and host factors: The trinity of oral post-acute sequelae of COVID-19 |
Joel Schwartz, Kristelle J. Capistrano, Joseph Gluck, Armita Hezarkhani, Afsar R. Naqvi |
| 25 |
[GO] |
2024―Apr―18 |
Passive immunotherapies for the next influenza pandemic |
Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Andrew Pekosz, Fabrizio Maggi, Arturo Casadevall |
| 26 |
[GO] |
2024―Mrz―21 |
Risk of kidney and liver diseases after COVID-19 infection: A systematic review and meta-analysis |
Bei Pan, Xiaoman Wang, Honghao Lai, Robin W. M. Vernooij, Xiyuan Deng, Ning Ma, Dan Li, Jiajie Huang, Weilong Zhao, Jinling Ning, Jianing Liu, Jinhui Tian, Long Ge, Kehu Yang |
| 27 |
[GO] |
2024―Mrz―06 |
Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS-CoV-2 and other respiratory viruses: A comprehensive review |
Chiranjib Chakraborty, Manojit Bhattacharya, Sang-Soo Lee |
| 28 |
[GO] |
2024―Feb―03 |
Duration of protective immunity following COVID-19 vaccination of individuals with underlying health conditions: A rapid review |
Kieran A. Walsh, Helen O’Donnell, Mark O’Loughlin, Heather Eames, Jingjing Jiang, Katie M. O’Brien, Natasha Broderick, Kirsty K. O’Brien, Marie Carrigan, Laura Comber, Karen Cardwell, Joan Quigley, Susan M. Smith, Éamon Ó Murchú, Karina Butler, Brenda Corcoran, Kevin Connolly, Patricia Harrington, Máirín Ryan, Michelle O'Neill |
| 29 |
[GO] |
2024―Feb―01 |
Increased risk of new-onset cardiovascular disease after COVID-19: A systematic review and meta-analysis of 14 cohorts |
Mingyao Sun, Mengyuan Yuan, Honghao Lai, Qian Wang, Hengyang Wang, Lina Xing, Jinhui Tian, Zhigang Zhang, Long Ge |
| 30 |
[GO] |
2024―Jan―24 |
Immunogenicity, clinical efficacy and safety of additional second COVID-19 booster vaccines against Omicron and its subvariants: A systematic review |
Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, Sai Nikhila Ghanta, Anusha Bommasani, Anitha Kuttiappan, R. Padmavathi, Krishna Chaitanya Amerneni, Radhika Chikatipalli, Mohan Krishna Ghanta, Samarra Simha Reddy, K. Mythili Bai, Satya Prakash, G. Jogender, Madhavrao Chavan, S. Balakrishnan |
| 31 |
[GO] |
2024―Jan―09 |
An overview of SARS-CoV2 natural infections in companion animals: A systematic review of the current evidence |
Zahra Heydarifard, Ardalan Maleki Chegeni, Fatemeh Heydarifard, Bahram Nikmanesh, Vahid Salimi |
| 32 |
[GO] |
2024―Jan―09 |
The controversy of SARS-CoV-2 integration into the human genome |
Laith AL-Eitan, Ahmad Mihyar |
| 33 |
[GO] |
2024―Jan―05 |
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID-19 infection |
Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, Yeganeh Farnamian, Roya Naderi, Ladan Jalali |
| 34 |
[GO] |
2024―Jan―04 |
Prevalence and outcomes of upper gastrointestinal bleeding in COVID-19: A systematic review and meta-analysis |
Sawai Singh Rathore, Zario Shai Wint, Aman Goyal, Bijay Mukesh Jeswani, Ameer Mustafa Farrukh, María Alejandra Nieto-Salazar, Thanmai Reddy Thugu, Snigdha Erva, Raafay Mehmood, Adriana Carolina Toro-velandia, Hamam Aneis, Sunny Ratnani, Ibrahim Marouf Yasin Al Shyyab |
| 35 |
[GO] |
2023―Dez―30 |
Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials |
Jayesh Beladiya, Anup Kumar, Yogesh Vasava, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, Sandip Dholakia, Devang Sheth, Sai H. S. Boddu, Chirag Patel |
| 36 |
[GO] |
2023―Dez―29 |
Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid-19 |
Han Wang, Li Cheng, Lanlan Yu, Zhigang Guo |
| 37 |
[GO] |
2023―Dez―27 |
Evaluating fluvoxamine for the outpatient treatment of COVID-19: A systematic review and meta-analysis |
Jiawen Deng, Myron Moskalyk, Qi Kang Zuo, Cristian Garcia, Umaima Abbas, Harikrishnaa Ba Ramaraju, Daniel Rayner, Ye-Jean Park, Kiyan Heybati, Fangwen Zhou, Simran Lohit |
| 38 |
[GO] |
2023―Dez―21 |
Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID-19 |
Aroona Razzaq, Cyrollah Disoma, Yuzheng Zhou, Siyi Tao, Zongpeng Chen, Sixu Liu, Rong Zheng, Yongxing Zhang, Yujie Liao, Xuan Chen, Sijie Liu, Zijun Dong, Liangtao Xu, Xu Deng, Shanni Li, Zanxian Xia |
| 39 |
[GO] |
2023―Nov―29 |
Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis |
Yue Wang, Dong Chen, Yuancan Pan, Haiming Li, Weizhe Zhao, Taicheng Lu, Weijia Kong, Min Ding, Xiaomin Wang, Ganlin Zhang |
| 40 |
[GO] |
2023―Nov―23 |
Comparable performance of antigen-detecting rapid test by healthcare worker-collected and self-collected swabs for SARS-CoV-2 diagnostic: A systematic review and meta-analysis |
Samuel Johnson Kurniawan, Maria Mardalena Martini Kaisar, Helen Kristin, Soegianto Ali |
| 41 |
[GO] |
2023―Nov―17 |
Reply to Kleebayoon and Wiwanitkit on ‘Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis’ |
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Laurie Butler, Ai Koyanagi, Louis Jacob, Jae Il Shin, Lee Smith |
| 42 |
[GO] |
2023―Okt―05 |
COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes |
Bruno Azevedo Randi, Hermes Ryoiti Higashino, Vinícius Ponzio da Silva, Erick Menezes Xavier, Vanderson Rocha, Silvia Figueiredo Costa |
| 43 |
[GO] |
2023―Sep―28 |
Modulation of various host cellular machinery during COVID-19 infection |
Shivani Malvankar, Anjali Singh, Y. S. Ravi Kumar, Swetangini Sahu, Megha Shah, Yamini Murghai, Mahendra Seervi, Rupesh K. Srivastava, Bhupendra Verma |
| 44 |
[GO] |
2023―Sep―14 |
Lactate dehydrogenase contribution to symptom persistence in long COVID: A pooled analysis |
Raphael Udeh, Alberto Utrero-Rico, Xenia Dolja-Gore, Masoud Rahmati, Mark McEVoy, Tony Kenna |
| 45 |
[GO] |
2023―Aug―14 |
Appraisal of evidence reliability and applicability of Paxlovid as treatment for SARS-COV-2 infection: A systematic review |
Chang-tai Zhu, Jian-Yun Yin, Xiao-hua Chen, Ming Liu, Shi-gui Yang |
| 46 |
[GO] |
2023―Aug―02 |
SARS-CoV-2 in digital era: Diagnostic techniques and importance of nucleic acid quantification with digital PCRs |
N. Aravind Kumar, S. Aradhana, M. R. Vishnuraj |
| 47 |
[GO] |
2023―Jul―24 |
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID-19: An updated meta-analysis and trial sequential analysis |
Haokun Tian, Changsen Yang, Tiangang Song, Kechen Zhou, Lequan Wen, Ye Tian, Lirui Tang, Weikai Xu, Xinyuan Zhang |
| 48 |
[GO] |
2023―Jun―25 |
Strongyloides coinfection in COVID-19 patients treated with corticosteroids: A systematic review |
Sana Zulfiqar, Robin B. Gasser, Sahar Ghodsian, Mustafa Almukhtar, Celia Holland, Ali Rostami |
| 49 |
[GO] |
2023―Jun―21 |
Transmission of mpox in educational settings and risk of severe disease in children and adolescents-Let's not make the same mistakes as COVID-19 again |
Konstantinos Karampatsas, Asma Khalil, Paul T. Heath, Kirsty Le Doare, Shamez N. Ladhani |
| 50 |
[GO] |
2023―Jun―16 |
SARS-CoV-2 neutralising antibody therapies: Recent advances and future challenges |
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, Li Liu, Qiwen Liu, Yiyin Mai, Huihuang Chen, Baoying Lei, Shangwei Yu, Huihui Chen, Peiyan Zheng, Baoqing Sun |
| 51 |
[GO] |
2023―Jun―12 |
Host genetic determinants of COVID-19 susceptibility and severity: A systematic review and meta-analysis |
Setegn Eshetie, Pastor Jullian, Beben Benyamin, S. Hong Lee |
| 52 |
[GO] |
2023―Mai―05 |
Differentially-regulated miRNAs in COVID-19: A systematic review |
Waqar Ahmad, Bushra Gull, Jasmin Baby, Neena G. Panicker, Thanumol A. Khader, Shaima Akhlaq, Tahir A. Rizvi, Farah Mustafa |
| 53 |
[GO] |
2023―Apr―19 |
Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: A systematic review and meta-analysis |
Negin Farhadian, Sara Sharifi, Mahdi Taghadosi, Maryam Farhadian, Siavash Vaziri |
| 54 |
[GO] |
2023―Apr―17 |
Sex affects immune response capacity against COVID-19 infection |
Andrea Zovi, Francesco Ferrara, Roberto Langella, Fabiola Cavallaro, Antonio Vitiello |
| 55 |
[GO] |
2023―Apr―14 |
Comment on COVID-19 vaccination during pregnancy, COVID and maternal and neonatal outcomes |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 56 |
[GO] |
2023―Apr―08 |
Interleukin-6 inhibitory effect of natural product naringenin compared to a synthesised monoclonal antibody against life-threatening COVID-19 |
Melika AmeliMojarad, Mandana AmeliMojarad |
| 57 |
[GO] |
2023―Apr―06 |
Implications of potential clinically relevant interactions between COVID-19 vaccines and concomitant medications |
Osama A. Badary |
| 58 |
[GO] |
2023―Mrz―21 |
Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis |
Alireza Mohebbi, Habib Haybar, Fatemeh Nakhaei Moghaddam, Zahra Rasti, Mohammad Amin Vahid, Najmaldin Saki |
| 59 |
[GO] |
2023―Mrz―14 |
The role of corticosteroids may be different in patients with COVID-19 |
Xiaolu Shao, Qianghong Xu |
| 60 |
[GO] |
2023―Mrz―11 |
Efficacy of therapeutic plasma exchange in patients with severe COVID-19: A systematic review and meta-analysis |
Omar Ahmed Abdelwahab, Rehab Adel Diab, Khaled Saad Elsaeidy, Khaled Albakri, Mohamed El-Samahy, Omar Ramadan, Ahmed Negida, Ali Mohamed Seif, Mohamed N. Al-Alfy |
| 61 |
[GO] |
2023―Mrz―10 |
Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis |
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Laurie Butler, Ai Koyanagi, Louis Jacob, Jae Il Shin, Lee Smith |
| 62 |
[GO] |
2023―Mrz―07 |
Reactivation of herpesviruses during COVID-19: A systematic review and meta-analysis |
Arman Shafiee, Mohammad Mobin Teymouri Athar, Mohammad Javad Amini, Hamed Hajishah, Sepehr Siahvoshi, Mehrsa Jalali, Bahar Jahanbakhshi, Sayed-Hamidreza Mozhgani |
| 63 |
[GO] |
2023―Feb―18 |
Prevalence and clinical outcomes of COVID-19 in patients with pre-existing celiac disease: A systematic review and meta-analysis |
Sawai Singh Rathore, Felipe Velasquez-Botero, María Alejandra Nieto-Salazar, Thomas C. Flowers, Jamal Hasan, Ashwani Kumar Parashar, Khurram Tanveer, Hamam Aneis, Ayotunde Isaac Buremoh, Keturah Yusuf, Khalil Khalil, Adriana Carolina Toro-Velandia, Shireen Kh. Sabeeh |
| 64 |
[GO] |
2023―Feb―18 |
Cardiac manifestations in children with the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection: Systematic review and meta-analysis |
Márcio Antonio Ferreira Arantes Junior, Ana Flávia Conegundes, Bárbara Castello Branco Miranda, Alexia Stenner Rodrigues Radicchi Campos, Ana Luiza França Vieira, Matheus Daniel Faleiro, Marco Antônio Campos, Erna Geessien Kroon, Aline Almeida Bentes |
| 65 |
[GO] |
2023―Feb―15 |
Clinical performance of rapid antigen tests in comparison to RT-PCR for SARS-COV-2 diagnosis in Omicron variant: A systematic review and meta-analysis |
Zahra Eslami Mohammadie, Saeed Akhlaghi, Saeed Samaeinasab, Shakiba Shaterzadeh-Bojd, Tannaz Jamialahmadi, Amirhossein Sahebkar |
| 66 |
[GO] |
2023―Feb―15 |
SARS-CoV-2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design |
Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Fazel Shokri |
| 67 |
[GO] |
2023―Feb―15 |
Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system |
Philipp Niklas Ostermann, Heiner Schaal |
| 68 |
[GO] |
2023―Feb―13 |
Quercetin for the treatment of COVID-19 patients: A systematic review and meta-analysis |
Huzaifa Ahmad Cheema, Aruba Sohail, Areej Fatima, Abia Shahid, Muhammad Shahzil, Mohammad Ebad Ur Rehman, Rehmat Ullah Awan, Sampath Chinnam, Abdulqadir J. Nashwan |
| 69 |
[GO] |
2023―Feb―02 |
The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities |
Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto |
| 70 |
[GO] |
2023―Jan―09 |
Efficacy and safety of tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: A systematic review and meta-analysis |
Arto Yuwono Soeroto, Theo Audi Yanto, Andree Kurniawan, Timotius Ivan Hariyanto |
| 71 |
[GO] |
2023―Jan―05 |
Anakinra was not associated with lower mortality in hospitalised COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials |
Wenli Shang, Yingying Zhang, Guizuo Wang, Dong Han |
| 72 |
[GO] |
2022―Dez―12 |
COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis |
Min Ho Lee, Han Jacob Li, Paul Wasuwanich, Sung Eun Kim, Jong Yeob Kim, Gwang Hun Jeong, Seoyeon Park, Jae Won Yang, Min Seo Kim, Dong Keon Yon, Seung Won Lee, Ai Koyanagi, Louis Jacob, Eun-Young Kim, Jae Hee Cheon, Jae Il Shin, Lee Smith |
| 73 |
[GO] |
2022―Dez―06 |
Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis |
Mahdi Taghadosi, Elham Safarzadeh, Ali Asgarzadeh, Seyed Askar Roghani, Afsaneh Shamsi, Cyrus Jalili, Shirin Assar, Parviz Soufivand, Mehran Pournazari, Parisa Feizollahi, Mohammad Hossein Nicknam, Vahid Asghariazar, Siavash Vaziri, Hossein Shahriari, Asadollah Mohammadi |
| 74 |
[GO] |
2022―Dez―01 |
B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone? |
Sourabh Soni, Yohannes A. Mebratu |
| 75 |
[GO] |
2022―Nov―24 |
Genetics, structure, transmission, epidemiology, immune response, and vaccine efficacies of the SARS-CoV-2 Delta variant: A comprehensive review |
Han Li, Chelsea-Jane Arcalas, Junmin Song, Masoud Rahmati, Seoyeon Park, Ai Koyanagi, Seung Won Lee, Dong Keon Yon, Jae Il Shin, Lee Smith |
| 76 |
[GO] |
2022―Nov―08 |
Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection |
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Ghosh, Samah A. Loutfy, Sara Sami ElKaffas, Nasra F. Abdel Fattah, Mohamed Hessien |
| 77 |
[GO] |
2022―Okt―13 |
Efficacy and safety of sotrovimab in patients with COVID-19: A rapid review and meta-analysis |
Bahman Amani, Behnam Amani |
| 78 |
[GO] |
2022―Sep―23 |
SARS-CoV-2 Omicron and its current known unknowns: A narrative review |
Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Hau Nguyen Thi Hien, I-Chun Hung, Mai Ngoc Luu, Zeeshan Ali Khan, Nguyen Thanh An, Van Phu Tran, Wei Jun Lee, Jeza Muhamad Abdul Aziz, Tasnim Ali, Shyam Prakash Dumre, Nguyen Tien Huy |
| 79 |
[GO] |
2022―Sep―13 |
Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis |
Robert Marcec, Vinko Michael Dodig, Igor Radanovic, Robert Likic |
| 80 |
[GO] |
2022―Sep―03 |
Testosterone and Covid-19: An update |
Aksam Yassin, Ridwan Sabsigh, Raed M. Al-Zoubi, Omar M. Aboumarzouk, Mustafa Alwani, Joanne Nettleship, Daniel Kelly |
| 81 |
[GO] |
2022―Aug―27 |
Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: A meta-analysis |
Sawai Singh Rathore, Sharvi Oberoi, Kinza Iqbal, Keshav Bhattar, Guadalupe Abigail Benítez-López, María Alejandra Nieto-Salazar, Felipe Velasquez-Botero, Guillermo Andrés Moreno Cortes, Jonathan Hilliard, Chinelo Chioma Madekwe, Chika Chizitelu Madekwe, Thomas C. Flowers, Khalil Khalil |
| 82 |
[GO] |
2022―Aug―27 |
Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review |
Mohammad Mahdi Rezaei Tolzali, Maryam Noori, Pourya Shokri, Shayan Rahmani, Shokoufeh Khanzadeh, Seyed Aria Nejadghaderi, Asra Fazlollahi, Mark J. M. Sullman, Kuljit Singh, Ali-Asghar Kolahi, Shahnam Arshi, Saeid Safiri |
| 83 |
[GO] |
2022―Aug―27 |
Haemagglutinin, neuraminidase and haemagglutinin esterase on the surface of SARS-CoV-2? |
Emad Behboudi, Hossein Teimouri |
| 84 |
[GO] |
2022―Aug―27 |
Response to the letter, entitled ‘Haemagglutinin, neuraminidase and haemagglutinin esterase on the surface of SARS-CoV-2?’ |
Rania Hamdy, Sameh S. M. Soliman |
| 85 |
[GO] |
2022―Aug―16 |
Effect of corticosteroid therapy on mortality in COVID-19 patients-A systematic review and meta-analysis |
Chirag Patel, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, Devang Sheth, Jayesh V. Beladiya |
| 86 |
[GO] |
2022―Jul―20 |
Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission |
Lok Bahadur Shrestha, Charles Foster, William Rawlinson, Nicodemus Tedla, Rowena A. Bull |
| 87 |
[GO] |
2022―Jul―12 |
The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis |
Zorana Dobrijević, Nikola Gligorijević, Miloš Šunderić, Ana Penezić, Goran Miljuš, Sergej Tomić, Olgica Nedić |
| 88 |
[GO] |
2022―Jun―10 |
Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis |
Hanna Krumbein, Lara S. Kümmel, Paraskevi C. Fragkou, Clemens Thölken, Ben L. Hünerbein, Rieke Reiter, Konstantinos A. Papathanasiou, Harald Renz, Chrysanthi Skevaki |
| 89 |
[GO] |
2022―Jun―04 |
Recent insights into SARS-CoV-2 omicron variant |
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, Keith Pardee |
| 90 |
[GO] |
2022―Mai―27 |
The role of cytokines and their antagonists in the treatment of COVID-19 patients |
Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, Amirreza Allahgholipour, Seyed Rouhollah Miri, Terence T. Sio, Mark J. M. Sullman, Kristin Carson-Chahhoud, Soheil Ebrahimpour |
| 91 |
[GO] |
2022―Mai―18 |
Potential intestinal infection and faecal-oral transmission of human coronaviruses |
Tingting Ning, Si Liu, Junxuan Xu, Yi Yang, Nan Zhang, Sian Xie, Li Min, Shutian Zhang, Shengtao Zhu, Youchun Wang |
| 92 |
[GO] |
2022―Mai―02 |
Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies |
Mona Sadeghalvad, Amir Hossein Mansourabadi, Maryam Noori, Seyed Aria Nejadghaderi, Masoomeh Masoomikarimi, Masoumeh Alimohammadi, Nima Rezaei |
| 93 |
[GO] |
2022―Apr―28 |
Biomarker based biosensors: An opportunity for diagnosis of COVID-19 |
Reza Khaksarinejad, Zohreh Arabpour, Leila RezaKhani, Farzad Parvizpour, Yousef Rasmi |
| 94 |
[GO] |
2022―Apr―21 |
Omicron - The new SARS-CoV-2 challenge? |
A. Lino, M. A. Cardoso, P. Martins-Lopes, H. M. R. Gonçalves |
| 95 |
[GO] |
2022―Apr―13 |
Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines |
Narasimha M. Beeraka, Olga A. Sukocheva, Elena Lukina, Junqi Liu, Ruitai Fan |
| 96 |
[GO] |
2022―Apr―13 |
Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis |
Masoud Rahmati, Mahdieh Molanouri Shamsi, Kayvan Khoramipour, Fatemeh Malakoutinia, Wongi Woo, Seoyeon Park, Dong Keon Yon, Seung Won Lee, Jae Il Shin, Lee Smith |
| 97 |
[GO] |
2022―Apr―13 |
Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysis |
Samuel J. Minkove, Junfeng Sun, Yan Li, Xizhong Cui, Diane Cooper, Peter Q. Eichacker, Parizad Torabi-Parizi |
| 98 |
[GO] |
2022―Apr―13 |
Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach |
Camilla Costa Silva, Clea Nazaré Carneiro Bichara, Francisca Regina Oliveira Carneiro, Vera Regina da Cunha Menezes Palacios, Ana Virgínia Soares Van den Berg, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão |
| 99 |
[GO] |
2022―Apr―05 |
Reflections after 2 years of COVID-19 pandemic |
Daniele Focosi, Arturo Casadevall, Fabrizio Maggi, Guido Antonelli |
| 100 |
[GO] |
2022―Apr―02 |
Assessing severe acute respiratory syndrome coronavirus 2 infectivity by reverse-transcription polymerase chain reaction: A systematic review and meta-analysis |
Alexey Fomenko, Stephanie Weibel, Helia Moezi, Kristina Menger, Christine Schmucker, Maria-Inti Metzendorf, Edith Motschall, Valeria Falcone, Daniela Huzly, Marcus Panning, Gerta Rücker, Hartmut Hengel |
| 101 |
[GO] |
2022―Mrz―31 |
Antioxidant/anti-inflammatory effect of Mg
2+
in coronavirus disease 2019 (COVID-19) |
Yalith Lyzet Arancibia-Hernández, Ana Karina Aranda-Rivera, Alfredo Cruz-Gregorio, José Pedraza-Chaverri |
| 102 |
[GO] |
2022―Mrz―29 |
Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS-CoV-2: A rapid review |
Kieran A. Walsh, Natasha Broderick, Susan Ahern, Christopher G. Fawsitt, Katie M. O’Brien, Marie Carrigan, Patricia Harrington, Michelle O’Neill, Susan M. Smith, Susan Spillane, Conor Teljeur, Máirín Ryan |
| 103 |
[GO] |
2022―Mrz―11 |
Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible |
Daniele Focosi, Massimo Franchini |
| 104 |
[GO] |
2022―Mrz―10 |
Prevalence of oral manifestations in COVID-19: A systematic review |
Preeti Sharma, Sangeeta Malik, Vijay Wadhwan, Suhasini Gotur Palakshappa, Roli Singh |
| 105 |
[GO] |
2022―Mrz―05 |
COVID-19 outcomes in paediatric cancer: A large scale pooled meta-analysis of 984 cancer patients |
Amr Ehab El-Qushayri, Amira Yasmine Benmelouka, Abdullah Dahy, Mohammad Rashidul Hashan |
| 106 |
[GO] |
2022―Mrz―03 |
SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management |
Chowdhury Nusaiba Binte Sayed Prapty, Raad Rahmat, Yusha Araf, Samiha Kamal Shounak, Tanjim Ishraq Rahaman, Mohammad Jakir Hosen, Chunfu Zheng, Md. Golzar Hossain |
| 107 |
[GO] |
2022―Feb―25 |
Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence |
Amr Ehab El-Qushayri, Ahmed Mostafa Ahmed Kamel, Abdullah Reda, Sherief Ghozy |
| 108 |
[GO] |
2022―Feb―09 |
Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches |
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian |
| 109 |
[GO] |
2022―Feb―03 |
SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review |
Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, Seyed Rouhollah Miri, Terence T. Sio, Mark J. M. Sullman, Kristin Carson-Chahhoud, Florian Langer, Soheil Ebrahimpour |
| 110 |
[GO] |
2022―Jan―08 |
Genetic polymorphisms of
ACE1
,
ACE2
, and
TMPRSS2
associated with COVID-19 severity: A systematic review with meta-analysis |
Wacharapol Saengsiwaritt, Jiraphun Jittikoon, Usa Chaikledkaew, Wanvisa Udomsinprasert |
| 111 |
[GO] |
2022―Jan―06 |
Great expectations: Living with and not dying from Covid-19 |
Philip P. Mortimer |
| 112 |
[GO] |
2021―Dez―27 |
Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review |
Saba Zanganeh, Nima Goodarzi, Mohammad Doroudian, Elaheh Movahed |
| 113 |
[GO] |
2021―Dez―18 |
Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series |
Asra Fazlollahi, Mahdi Zahmatyar, Maryam Noori, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Reza Shekarriz-Foumani, Ali-Asghar Kolahi, Kuljit Singh, Saeid Safiri |
| 114 |
[GO] |
2021―Dez―10 |
Caution should be exercised when assessing ivermectin for the treatment of COVID-19 in systematic reviews |
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Kyra Kavanagh |
| 115 |
[GO] |
2021―Dez―07 |
Complement inhibition: A possible therapeutic approach in the fight against Covid-19 |
Niloofar Deravi, Elahe Ahsan, Mobina Fathi, Parastoo Hosseini, Shirin Yaghoobpoor, Ramin Lotfi, Atieh Pourbagheri-Sigaroodi, Davood Bashash |
| 116 |
[GO] |
2021―Dez―03 |
Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics? |
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, Fabrizio Maggi, Arturo Casadevall |
| 117 |
[GO] |
2021―Nov―10 |
Covid-19 vaccines and variants of concern: A review |
Ikbel Hadj Hassine |
| 118 |
[GO] |
2021―Nov―02 |
Marine mollusc extracts-Potential source of SARS-CoV-2 antivirals |
Rebecca L. Pedler, Peter G. Speck |
| 119 |
[GO] |
2021―Okt―30 |
Role of ORF8a as accessory protein in apoptosis induction in SARS-CoV-2 infection |
Milad Zandi, Hassan Karami |
| 120 |
[GO] |
2021―Okt―29 |
A comparison with historical influenza prompts better planning for Covid-19 and future pandemics, and gives grounds for optimism |
Philip Mortimer |
| 121 |
[GO] |
2021―Okt―26 |
Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study |
Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ali Teimoori, Ebrahim Azimi, Nabbi Emamipour, Marzieh Eghtedardoost, Vahid Siavashi, Hamidreza Jamshidi, Mohammadreza Hosseinpour, Mohammad Taqavian, Hasan Jalili |
| 122 |
[GO] |
2021―Okt―22 |
Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities |
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Feizollah Mansouri, Terence T. Sio, Mark J. M. Sullman, Kristin Carson-Chahhoud, Rezvan Hosseinzadeh, Mohammad Barary, Soheil Ebrahimpour |
| 123 |
[GO] |
2021―Okt―21 |
Hospitalised versus outpatient COVID-19 patients' background characteristics and comorbidities: A systematic review and meta-analysis |
Paola P. Mattey-Mora, Connor A. Begle, Candice K. Owusu, Chen Chen, Maria A. Parker |
| 124 |
[GO] |
2021―Okt―16 |
The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis |
Harapan Harapan, Jonny Karunia Fajar, Supriono Supriono, Gatot Soegiarto, Laksmi Wulandari, Fiha Seratin, Nyoman Gede Prayudi, Dara Puspita Dewi, Maria Theresia Monica Elsina, Lasarus Atamou, Sinta Wiranata, Dhito Pemi Aprianto, Erlin Friska, D. Fitria Sari Firdaus, Makdum Alaidin, Firdha Aprillia Wardhani, Milda Husnah, Nurdina Wahyu Hidayati, Yeni Hendriyanti, Kristia Wardani, Arde Evatta, Reizal Audi Manugan, Wiryawan Pradipto, Ade Rahmawati, Fredo Tamara, Aditya Indra Mahendra, Firzan Nainu, Budi Santoso, Chandra Adi Irawan Primasatya, Nindy Tjionganata, Hendarto Arif Budiman |
| 125 |
[GO] |
2021―Okt―08 |
Protection offered by SARS coronavirus 2 vaccines against disease and infection |
Paul D. Griffiths |
| 126 |
[GO] |
2021―Okt―01 |
Behaviour of aerosols and their role in the transmission of SARS-CoV-2; a scoping review |
José Miguel Robles-Romero, Gloria Conde-Guillén, Juan Carlos Safont-Montes, Francisca María García-Padilla, Macarena Romero-Martín |
| 127 |
[GO] |
2021―Sep―30 |
Cell death mechanisms involved in cell injury caused by SARS-CoV-2 |
Maríllya Morais da Silva, André Silva Lira de Lucena, Sergio de Sá Leitão Paiva Júnior, Vanessa Mylenna Florêncio De Carvalho, Priscilla Stela Santana de Oliveira, Michelle Melgarejo Rosa, Moacyr Jesus Barreto de Melo Rego, Maira Galdino da Rocha Pitta, Michelly Cristiny Pereira |
| 128 |
[GO] |
2021―Sep―28 |
Pharmacological interventions to prevent Covid-19 disease: A rapid review |
Karen Cardwell, Eamon O Murchu, Paula Byrne, Natasha Broderick, Kieran A. Walsh, Sinéad M. O'Neill, Susan M. Smith, Patricia Harrington, Máirín Ryan, Michelle O'Neill |
| 129 |
[GO] |
2021―Sep―24 |
Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis |
Jingwen Peng, Meihua Fu, Huan Mei, Hailin Zheng, Guanzhao Liang, Xiaodong She, Qiong Wang, Weida Liu |
| 130 |
[GO] |
2021―Sep―21 |
The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression |
Zheng Yao Low, Ashley Jia Wen Yip, Vincent T. K. Chow, Sunil K. Lal |
| 131 |
[GO] |
2021―Sep―17 |
Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection |
Daniela Mateus, Ana Isabel Sebastião, Mylène A. Carrascal, Anália do Carmo, Ana Miguel Matos, Maria Teresa Cruz |
| 132 |
[GO] |
2021―Sep―13 |
Ethnicity as a risk factor for vitamin D deficiency and undesirable COVID-19 outcomes |
Amir Reza Akbari, Maaz Khan, William Adeboye, Lawrence Hin Hai Lee, Sabbir Islam Chowdhury |
| 133 |
[GO] |
2021―Sep―13 |
Laboratory biomarkers and prognosis in Covid-19, where do we stand? |
Alisha Israni, Christopher J. Goulden, Amer Harky |
| 134 |
[GO] |
2021―Sep―09 |
Long-term side effects and lingering symptoms post COVID-19 recovery |
Mohammad Zarei, Deepanwita Bose, Masoud Nouri-Vaskeh, Vida Tajiknia, Ramin Zand, Mehdi Ghasemi |
| 135 |
[GO] |
2021―Sep―08 |
Severe acute respiratory syndrome-2 encodes hemagglutinin esterase? |
Milad Zandi |
| 136 |
[GO] |
2021―Sep―02 |
Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis |
Le Huu Nhat Minh, Ali Ahmed-Fouad Abozaid, Nam Xuan Ha, Loc Le Quang, Abdelrahman Gamil Gad, Ranjit Tiwari, Tran Nhat-Le, Dinh Kim Quyen, Balqees AL-Manaseer, Nguyen Dang Kien, Nguyen Lam Vuong, Ahmad Helmy Zayan, Le Huu Hanh Nhi, Kadek Agus Surya Dila, Joseph Varney, Nguyen Tien Huy |
| 137 |
[GO] |
2021―Aug―14 |
Effectiveness of public health measures to prevent the transmission of SARS-CoV-2 at mass gatherings: A rapid review |
Kieran A. Walsh, Barrie Tyner, Natasha Broderick, Patricia Harrington, Michelle O’Neill, Christopher G. Fawsitt, Karen Cardwell, Susan M. Smith, Máire A. Connolly, Máirín Ryan |
| 138 |
[GO] |
2021―Aug―07 |
Mesenchymal stem cells and their derived exosomes to combat Covid-19 |
Maryam Yousefi Dehbidi, Nima Goodarzi, Mohammad H. Azhdari, Mohammad Doroudian |
| 139 |
[GO] |
2021―Aug―02 |
Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020? |
João Locke Araújo, Diego Menezes, Julia Maria Saraiva-Duarte, Luciana Ferreira, Renato Aguiar, Renan Souza |
| 140 |
[GO] |
2021―Aug―02 |
An overview on the seven pathogenic human coronaviruses |
Mina Mobini Kesheh, Parastoo Hosseini, Saber Soltani, Milad Zandi |
| 141 |
[GO] |
2021―Jul―31 |
Authors’ response: Ethnicity and vitamin D supplementations for COVID-19 |
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan |
| 142 |
[GO] |
2021―Jul―19 |
Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies |
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, Kristin Carson-Chahhoud, Khalil Ansarin, Ali-Asghar Kolahi, Saeid Safiri |
| 143 |
[GO] |
2021―Jul―14 |
The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis |
Amr Ehab El-Qushayri, Sherief Ghozy, Abdullah Reda, Ahmed Mostafa Ahmed Kamel, Alzhraa Salah Abbas, Adam A. Dmytriw |
| 144 |
[GO] |
2021―Jul―10 |
Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis |
Tejpal Gupta, Prafulla Thakkar, Babusha Kalra, Sadhana Kannan |
| 145 |
[GO] |
2021―Jul―06 |
Rational procedures for this and the next virus pandemic |
Philip P Mortimer |
| 146 |
[GO] |
2021―Jul―03 |
Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments |
Biswajit Maiti, Karanth Padyana Anupama, Praveen Rai, Indrani Karunasagar, Iddya Karunasagar |
| 147 |
[GO] |
2021―Jul―02 |
Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients |
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Mandana Afsharian, Kiarash Saleki, Mohammad Barary, Soheil Ebrahimpour |
| 148 |
[GO] |
2021―Jul―01 |
Persistence of humoral response upon SARS-CoV-2 infection |
Andrea Knies, Dennis Ladage, Ralf J. Braun, Janine Kimpel, Miriam Schneider |
| 149 |
[GO] |
2021―Jun―27 |
Vitamin D supplementation and Covid-19 outcomes: A systematic review, meta-analysis and meta-regression |
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan |
| 150 |
[GO] |
2021―Jun―27 |
Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S-glycoprotein, infectivity, re-infectivity, immune escape and vaccines activity |
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma |
| 151 |
[GO] |
2021―Jun―24 |
Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19 |
Ranjita Misra, Sarbari Acharya, Nehru Sushmitha |
| 152 |
[GO] |
2021―Jun―07 |
Ivermectin and outcomes from Covid-19 pneumonia: A systematic review and meta-analysis of randomized clinical trial studies |
Timotius Ivan Hariyanto, Devina Adella Halim, Jane Rosalind, Catherine Gunawan, Andree Kurniawan |
| 153 |
[GO] |
2021―Jun―07 |
Role of red blood cell distribution width, as a prognostic indicator in COVID-19: A systematic review and meta-analysis |
Soumya Sarkar, Sundara Kannan, Puneet Khanna, Akhil Kant Singh |
| 154 |
[GO] |
2021―Jun―03 |
Epidemiology, prognosis and management of potassium disorders in Covid-19 |
Maryam Noori, Seyed A. Nejadghaderi, Mark J. M. Sullman, Kristin Carson-Chahhoud, Ali-Asghar Kolahi, Saeid Safiri |
| 155 |
[GO] |
2021―Jun―03 |
Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials |
Ahmed M. Kamel, Mona S. A. Monem, Nour A. Sharaf, Nada Magdy, Samar F. Farid |
| 156 |
[GO] |
2021―Mai―27 |
Quantifying the risk of SARS-CoV-2 reinfection over time |
Eamon O Murchu, Paula Byrne, Paul G. Carty, Cillian De Gascun, Mary Keogan, Michelle O’Neill, Patricia Harrington, Máirín Ryan |
| 157 |
[GO] |
2021―Mai―24 |
Oral manifestations of Covid-19-A literature review |
Huma Farid, Madiha Khah, Shizrah Jamal, Robia Ghafoor |
| 158 |
[GO] |
2021―Mai―14 |
The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review |
Pourya Shokri, Saeid Golmohammadi, Maryam Noori, Seyed Aria Nejadghaderi, Kristin Carson-Chahhoud, Saeid Safiri |
| 159 |
[GO] |
2021―Mai―14 |
A rapid review of measures to support people in isolation or quarantine during the Covid-19 pandemic and the effectiveness of such measures |
Karen Cardwell, Sinéad M. O’Neill, Barrie Tyner, Natasha Broderick, Kirsty O’Brien, Susan M. Smith, Patricia Harrington, Mairin Ryan, Michelle O’Neill |
| 160 |
[GO] |
2021―Apr―22 |
Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials |
Timothée Klopfenstein, Vincent Gendrin, N'dri Juliette Kadiane-Oussou, Thierry Conrozier, Souheil Zayet |
| 161 |
[GO] |
2021―Apr―01 |
Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far? |
Abdellatif Bouayad |
| 162 |
[GO] |
2021―Mrz―25 |
Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models |
Ece Egilmezer, William D Rawlinson |
| 163 |
[GO] |
2021―Mrz―16 |
Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines |
Daniele Focosi, Fabrizio Maggi |
| 164 |
[GO] |
2021―Mrz―16 |
Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus |
Farzaneh Darbeheshti, Mojdeh Mahdiannasser, Bruce D Uhal, Shuji Ogino, Sudhir Gupta, Nima Rezaei |
| 165 |
[GO] |
2021―Mrz―13 |
Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France |
Chloé Dimeglio, Marcel Miedougé, Jean-Michel Loubes, Jean-Michel Mansuy, Jacques Izopet |
| 166 |
[GO] |
2021―Mrz―05 |
Vaccines for SARS coronavirus 2 and the new normal in vaccinology |
P. D. Griffiths |
| 167 |
[GO] |
2021―Mrz―01 |
Sex-based differences in severity and mortality in COVID-19 |
Mustafa Alwani, Aksam Yassin, Raed M. Al-Zoubi, Omar M. Aboumarzouk, Joanne Nettleship, Daniel Kelly, Ahmad R. AL-Qudimat, Ridwan Shabsigh |
| 168 |
[GO] |
2021―Mrz―01 |
Covid-19 and oral diseases: Crosstalk, synergy or association? |
Daniela A. Brandini, Aline S. Takamiya, Pari Thakkar, Samantha Schaller, Rani Rahat, Afsar R. Naqvi |
| 169 |
[GO] |
2021―Feb―23 |
Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics |
Jenifer Kiem Aviani, Danny Halim, Arto Yuwono Soeroto, Tri Hanggono Achmad, Tono Djuwantono |
| 170 |
[GO] |
2021―Feb―20 |
C-reactive protein as an effector molecule in Covid-19 pathogenesis |
Jesús A. Mosquera-Sulbaran, Adriana Pedreañez, Yenddy Carrero, Diana Callejas |
| 171 |
[GO] |
2021―Feb―17 |
SARS-CoV-2, Covid-19, and the debunking of conspiracy theories |
Mohamad S. Hakim |
| 172 |
[GO] |
2021―Jan―21 |
Loop-mediated isothermal amplification (LAMP): An effective molecular point-of-care technique for the rapid diagnosis of coronavirus SARS-CoV-2 |
Melek Chaouch |
| 173 |
[GO] |
2021―Jan―20 |
Coronavirus disease 2019 as a syndemic |
Griffiths Paul |
| 174 |
[GO] |
2021―Jan―15 |
Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients |
Mohammad Mahmudur Rahman, Maruf Hasan, Asif Ahmed |
| 175 |
[GO] |
2021―Jan―15 |
Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19 |
Jiezhong Chen, Sean Hall, Luis Vitetta |
| 176 |
[GO] |
2021―Jan―15 |
Lipid-based therapies against SARS-CoV-2 infection |
Eman Humaid Alketbi, Rania Hamdy, Abdalla El-Kabalawy, Viktorija Juric, Marc Pignitter, Kareem Mosa, Ahmed M. Almehdi, Ali A. El-Keblawy, Sameh S. M. Soliman |
| 177 |
[GO] |
2021―Jan―02 |
Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis |
Maryamsadat Jafari, Ali Pormohammad, Saeideh Aghayari Sheikh Neshin, Saied Ghorbani, Deepanwita Bose, Shohreh Alimohammadi, Sedigheh Basirjafari, Mehdi Mohammadi, Cody Rasmussen-Ivey, Mohammad Hossein Razizadeh, Masoud Nouri-Vaskeh, Mohammad Zarei |
| 178 |
[GO] |
2021―Jan―02 |
How strong is the evidence that it is possible to get SARS-CoV-2 twice? A systematic review |
Larabe Farrukh, Aqsa Mumtaz, Muhammad K. Sana |
| 179 |
[GO] |
2020―Dez―31 |
Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings |
Ish K. Midha, Nilesh Kumar, Amit Kumar, Taruna Madan |
| 180 |
[GO] |
2020―Dez―26 |
Classical and alternative receptors for SARS-CoV-2 therapeutic strategy |
Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub |
| 181 |
[GO] |
2020―Dez―25 |
Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm |
Ian A. Clark |
| 182 |
[GO] |
2020―Dez―19 |
How artificial intelligence may help the Covid-19 pandemic: Pitfalls and lessons for the future |
Yashpal Singh Malik, Shubhankar Sircar, Sudipta Bhat, Mohd Ikram Ansari, Tripti Pande, Prashant Kumar, Basavaraj Mathapati, Ganesh Balasubramanian, Rahul Kaushik, Senthilkumar Natesan, Sayeh Ezzikouri, Mohamed E. El Zowalaty, Kuldeep Dhama |
| 183 |
[GO] |
2020―Dez―05 |
Population-based prevalence surveys during the Covid-19 pandemic: A systematic review |
Vinícius Bonetti Franceschi, Andressa Schneiders Santos, Andressa Barreto Glaeser, Janini Cristina Paiz, Gabriel Dickin Caldana, Carem Luana Machado Lessa, Amanda de Menezes Mayer, Julia Gonçalves Küchle, Paulo Ricardo Gazzola Zen, Alvaro Vigo, Ana Trindade Winck, Liane Nanci Rotta, Claudia Elizabeth Thompson |
| 184 |
[GO] |
2020―Dez―05 |
Immunity and inflammatory biomarkers in COVID-19: A systematic review |
Ana Paula D. Iwamura, Marielen R. Tavares da Silva, Ana Luísa Hümmelgen, Paulo V. Soeiro Pereira, Angela Falcai, Anete Sevciovic Grumach, Ekaterini Goudouris, Antônio Condino Neto, Carolina Prando |
| 185 |
[GO] |
2020―Nov―21 |
A systematic meta-analysis of immune signatures in patients with COVID-19 |
Kun Liu, Tong Yang, Xue-Fang Peng, Shou-Ming Lv, Xiao-lei Ye, Tian-Shuo Zhao, Jia-Chen Li, Zhong-Jun Shao, Qing-Bin Lu, Jing-Yun Li, Wei Liu |
| 186 |
[GO] |
2020―Nov―18 |
Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review |
Salma Younes, Nadin Younes, Farah Shurrab, Gheyath K. Nasrallah |
| 187 |
[GO] |
2020―Nov―18 |
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment |
Laith N. AL-Eitan, Saif Z. Alahmad |
| 188 |
[GO] |
2020―Nov―11 |
Impact of COVID-19 on polio vaccination in Pakistan: a concise overview |
Misbahud Din, Hammad Ali, Mudassir Khan, Abdul Waris, Sana Ullah, Muhammad Kashif, Sidra Rehman, Muhammad Ali |
| 189 |
[GO] |
2020―Nov―07 |
The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence |
Karen Cardwell, Karen Jordan, Paula Byrne, Susan M. Smith, Patricia Harrington, Mairin Ryan, Michelle O'Neill |
| 190 |
[GO] |
2020―Nov―05 |
Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta-analysis |
Daniel Mekonnen, Hylemariam Mihiretie Mengist, Awoke Derbie, Endalkachew Nibret, Abaineh Munshea, Hongliang He, Bofeng Li, Tengchuan Jin |
| 191 |
[GO] |
2020―Okt―31 |
Intricate interplay between Covid-19 and cardiovascular diseases |
Vishakh C. Keri, Amit Hooda, Parul Kodan, Brunda R L, Pankaj Jorwal, Naveet Wig |
| 192 |
[GO] |
2020―Okt―31 |
Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis |
Hozaifa Khalil Elsawah, Mohamed Ahmed Elsokary, Mahmoud Samy Abdallah, Ahmed Hanei ElShafie |
| 193 |
[GO] |
2020―Okt―26 |
YouTube as a source of patient information for Covid-19: An enhanced content-quality and audience engagement analysis |
Wajahat Mughal, Zahid Mohammed, Abdullah Zafar, Benyamin Alam |
| 194 |
[GO] |
2020―Okt―26 |
Airborne transmission of SARS-CoV-2 via aerosols |
Laura Comber, Eamon O Murchu, Linda Drummond, Paul G. Carty, Kieran A. Walsh, Cillian F. De Gascun, Máire A. Connolly, Susan M. Smith, Michelle O'Neill, Máirín Ryan, Patricia Harrington |
| 195 |
[GO] |
2020―Okt―22 |
Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review |
Laura Comber, Kieran A. Walsh, Karen Jordan, Kirsty K. O'Brien, Barbara Clyne, Conor Teljeur, Linda Drummond, Paul G. Carty, Cillian F. De Gascun, Susan M. Smith, Patricia Harrington, Máirín Ryan, Michelle O'Neill |
| 196 |
[GO] |
2020―Okt―15 |
Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects |
Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, Atefeh Afchangi, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, Mehdi Fazlalipour, Mohammad Hassan Pouriayevali, Tahmineh Jalali, Seyed Dawood Mousavi Nasab, Farzin Roohvand, Zabihollah Shoja |
| 197 |
[GO] |
2020―Okt―09 |
Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings |
Ali Pormohammad, Saied Ghorbani, Alireza Khatami, Mohammad Hossein Razizadeh, Ehsan Alborzi, Mohammad Zarei, Juan-Pablo Idrovo, Raymond J. Turner |
| 198 |
[GO] |
2020―Okt―06 |
Covid-19 and kidney injury: Pathophysiology and molecular mechanisms |
Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Saiedeh Razi Soofiyani, Sima Abediazar, Mohammadali M. Shoja, Mohammadreza Ardalan, Sepideh Zununi Vahed |
| 199 |
[GO] |
2020―Okt―06 |
Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies |
Ahmed M. Kamel, Mona Sobhy, Nada Magdy, Nirmeen Sabry, Samar Farid |
| 200 |
[GO] |
2020―Okt―06 |
Clotting disorder in severe acute respiratory syndrome coronavirus 2 |
Sujit Pujhari, Sanjeeta Paul, Jasmina Ahluwalia, Jason L. Rasgon |
| 201 |
[GO] |
2020―Okt―01 |
Is there light at the end of the Covid-19 tunnel? |
Philip P. Mortimer |
| 202 |
[GO] |
2020―Sep―25 |
The complexity of respiratory disease associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: From immunopathogenesis to respiratory therapy |
Luiz Fábio Falcão, Lucieny da Silva Pontes, Bruno Giovanni Afonso da Silva, Karen Margarete Vieira da Silva Franco, Luiz Adriano Costa, Rodrigo Santiago Barbosa Rocha, Juarez Antônio Simões Quaresma |
| 203 |
[GO] |
2020―Sep―23 |
Immune response following infection with
SARS-CoV
-2 and other coronaviruses: A rapid review |
Eamon O Murchu, Paula Byrne, Kieran A. Walsh, Paul G. Carty, Máire Connolly, Cillian De Gascun, Karen Jordan, Mary Keoghan, Kirsty K. O'Brien, Michelle O'Neill, Susan M. Smith, Conor Teljeur, Máirín Ryan, Patricia Harrington |
| 204 |
[GO] |
2020―Sep―23 |
Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development |
Sakthivel Suganya, Suresh Divya, Madasamy Parani |
| 205 |
[GO] |
2020―Sep―22 |
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? |
Jing Liu, Salim S. Virani, Mahboob Alam, Ali E. Denktas, Ihab Hamzeh, Umair Khalid |
| 206 |
[GO] |
2020―Sep―22 |
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy |
Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, Mauro Pistello |
| 207 |
[GO] |
2020―Sep―21 |
Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? |
Mohamed M. NasrAllah, Noha A. Osman, Mahmoud Elalfy, Paolo Malvezzi, Lionel Rostaing |
| 208 |
[GO] |
2020―Sep―19 |
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus |
Zhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li |
| 209 |
[GO] |
2020―Sep―18 |
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia |
Harapan Harapan, Mirza Ryan, Benediktus Yohan, Rufika Shari Abidin, Firzan Nainu, Ahmed Rakib, Israt Jahan, Talha Bin Emran, Irfan Ullah, Kritu Panta, Kuldeep Dhama, R. Tedjo Sasmono |
| 210 |
[GO] |
2020―Sep―18 |
Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes |
Esmaeil Farshi, Bahram Kasmapur, Anya Arad |
| 211 |
[GO] |
2020―Sep―16 |
SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects |
Shiqin Li, Sijia Li, Cyrollah Disoma, Rong Zheng, Mei Zhou, Aroona Razzaq, Pinjia Liu, Yuzheng Zhou, Zijun Dong, Ashuai Du, Jian Peng, Liqiang Hu, Jufang Huang, Pinghui Feng, Taijiao Jiang, Zanxian Xia |
| 212 |
[GO] |
2020―Sep―02 |
Interleukin-6 in Covid-19: A systematic review and
meta-analysis |
Eric A. Coomes, Hourmazd Haghbayan |
| 213 |
[GO] |
2020―Sep―02 |
SARS-CoV
-2 infection in people living with
HIV
: a systematic review |
Paola Costenaro, Chiara Minotti, Elisa Barbieri, Carlo Giaquinto, Daniele Donà |
| 214 |
[GO] |
2020―Aug―28 |
Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions |
Majid Teymoori-Rad, Sayed Mahdi Marashi |
| 215 |
[GO] |
2020―Aug―28 |
Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus (
MERS-CoV
) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressure |
Mohamed M. Ba Abduallah, Maged Gomaa Hemida |
| 216 |
[GO] |
2020―Aug―28 |
SARS-CoV
: Lessons learned; opportunities missed for
SARS-CoV
-2 |
Ian M. Davis |
| 217 |
[GO] |
2020―Aug―26 |
Alpha-1-antitrypsin
: A possible host protective factor against Covid-19 |
Mariana Braccialli Loyola, Thaís Tereza Aguiar Reis, Guilherme Xavier Lyra Malcher Oliveira, Julys Fonseca Palmeira, Gustavo A. Argañaraz, Enrique R. Argañaraz |
| 218 |
[GO] |
2020―Aug―11 |
Drugs against
SARS-CoV
-2: What do we know about their mode of action? |
Coralie Valle, Baptiste Martin, Franck Touret, Ashleigh Shannon, Bruno Canard, Jean-Claude Guillemot, Bruno Coutard, Etienne Decroly |
| 219 |
[GO] |
2020―Aug―05 |
Review: An insight into coronaviruses: Challenges, security and scope |
Niyati Shah, Vipul Davariya, Sanjeev K. Gupta, Pankaj Gajjar, Jitendra Parmar, Lancelot D'Cruz |
| 220 |
[GO] |
2020―Jul―31 |
Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV |
Abdellatif Bouayad |
| 221 |
[GO] |
2020―Jul―28 |
Toward better pandemic planning: An urgent priority |
Philip P. Mortimer |
| 222 |
[GO] |
2020―Jul―20 |
Novel coronavirus
SARS-CoV
-2 (Covid-19) dynamics inside the human body |
Asit Saha, Barsha Saha |
| 223 |
[GO] |
2020―Jul―20 |
Neuropathogenic human coronaviruses: A review |
Osama S. Abdelaziz, Zuraiha Waffa |
| 224 |
[GO] |
2020―Jul―13 |
Lessons from dermatology about inflammatory responses in Covid-19 |
Paulo Ricardo Criado, Carla Pagliari, Francisca Regina Oliveira Carneiro, Juarez Antonio Simões Quaresma |
| 225 |
[GO] |
2020―Jul―10 |
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection |
Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama, Harapan Harapan |
| 226 |
[GO] |
2020―Jul―09 |
Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review |
Richard A. Giovane, Shadi Rezai, Ellen Cleland, Cassandra E. Henderson |
| 227 |
[GO] |
2020―Jul―03 |
Covid-19: Time for a paradigm change |
Franco M. Buonaguro, Paolo A. Ascierto, Gene D. Morse, Luigi Buonaguro, Igor Puzanov, Maria Lina Tornesello, Christian Bréchot, Robert C. Gallo |
| 228 |
[GO] |
2020―Jul―02 |
Using heat to kill
SARS-CoV
-2 |
John P. Abraham, Brian D. Plourde, Lijing Cheng |
| 229 |
[GO] |
2020―Jun―30 |
Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection |
Heng Wee Tan, Yan-Ming Xu, Andy T. Y. Lau |
| 230 |
[GO] |
2020―Jun―15 |
YouTube
as a source of patient information for Coronavirus Disease (
COVID
-19): A
content-quality
and audience engagement analysis |
Tomasz Szmuda, Mohammad Talha Syed, Akshita Singh, Shan Ali, Cathrine Özdemir, Paweł Słoniewski |
| 231 |
[GO] |
2020―Jun―04 |
Emergence of novel coronavirus and progress toward treatment and vaccine |
Muhammad Muzamil Khan, Amna Noor, Asadullah Madni*, Mudassir Shafiq |
| 232 |
[GO] |
2020―Mai―20 |
The basic reproduction number of SARS-CoV-2 in Wuhan is about to die out, how about the rest of the World? |
Bootan Rahman, Evar Sadraddin, Annamaria Porreca |
| 233 |
[GO] |
2020―Mai―13 |
SARS
coronavirus 2; how many more examples do we need before the world commits to decisive action? |
P. D. Griffiths |
| 234 |
[GO] |
2020―Mai―12 |
The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved |
Philip P. Mortimer |
| 235 |
[GO] |
2020―Apr―21 |
Melatonin: Roles in influenza, Covid-19, and other viral infections |
George Anderson, Russel J. Reiter |
| 236 |
[GO] |
2020―Apr―17 |
Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures |
Ying Yan, Le Chang, Lunan Wang |
| 237 |
[GO] |
2020―Apr―08 |
Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS |
Mohsen Rokni, Vida Ghasemi, Zahra Tavakoli |
| 238 |
[GO] |
2020―Mrz―16 |
Clinical features of deaths in the novel coronavirus epidemic in China |
Char Leung |
| 239 |
[GO] |
2020―Mrz―05 |
Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses |
Reina Yamaji, Magdi D. Saad, Charles T. Davis, David E. Swayne, Dayan Wang, Frank Y.K. Wong, John W. McCauley, J.S. Malik Peiris, Richard J. Webby, Ron A.M. Fouchier, Yoshihiro Kawaoka, Wenqing Zhang |
